All In Biotech

Free tool

FAERS Monitor: Rebif

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103780 or its brand name (Rebif, Interferon Beta-1a). Reports on generic versions are filed under their own applications.

Reports

47,980

Serious

36,921

77% of reports

Hospitalization

17,271

Death reported

2,806

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • multiple sclerosis relapse4,095
  • fatigue2,997
  • injection site erythema2,959
  • influenza like illness2,933
  • fall2,554
  • headache2,455
  • injection site pain2,431
  • pain1,939
  • depression1,846
  • multiple sclerosis1,784
  • gait disturbance1,767
  • hypoaesthesia1,654
  • urinary tract infection1,579
  • asthenia1,577
  • nausea1,451

Reports by year received

View as table
YearReports
2004314
20051,651
2006571
20071,652
20082,032
20092,506
20103,611
20114,468
20124,809
20135,832
20143,083
20151,901
20161,806
20171,965
20181,969
20191,970
20201,537
20211,814
20221,632
20231,055
2024790
2025637
2026375

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,006,179 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
multiple sclerosis relapseSignal4,09527.827.099,749
multiple sclerosisSignal1,78416.916.225,821
influenza like illnessSignal2,93316.215.640,377
injection site erythemaSignal2,95910.710.325,505
hypoaesthesiaSignal1,6544.94.75,089
urinary tract infectionSignal1,5794.13.93,674
gait disturbanceSignal1,7674.13.94,097
depressionSignal1,8463.63.43,435
injection site painSignal2,4313.53.44,354
fallSignal2,5543.43.34,318
asthenia1,5771.81.8615
headache2,4551.71.7758
fatigue2,9971.71.6873
pain1,9391.41.3213
nausea1,4510.80.872

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.